“We are very excited about this association with the Rosenthal Lab,” said Dr. Eugene Seymour, MD, MPH, CEO of the Company, adding, “We will now be able to rapidly evaluate our anti-herpes therapeutics.”
Now is time to buy more shares on NNVC. $1 is a great price.
I have the intuition that it will soon change very quickly for the good of everybody.
A toast to NNVC !!